CNS Pharmaceuticals, Inc. (CNSP) stock
CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.89−0.73 (-20.17%)
Close on Nov 13, 2026Market cap $4.22MP/E –Yield –
CNS Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CNS Pharmaceuticals's enterprise value was -$14.69M on Nov 11, 2026, against -$5.88M a year earlier. Over the last 5 years it ranged from -$14.69M to $11.57B, with a median of $625.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$14.69M | – |
| 2025 | Dec 31, 2025 | -$6.85M | -100.3% |
| 2024 | Dec 31, 2024 | $2.41B | -24.8% |
| 2023 | Dec 29, 2023 | $3.20B | +67.4% |
| 2022 | Dec 30, 2022 | $1.91B | -83.4% |
| 2021 | Dec 31, 2021 | $11.57B | -35.0% |
| 2020 | Dec 31, 2020 | $17.78B | -44.8% |
| 2019 | Dec 31, 2019 | $32.21B | – |
See a number that looks wrong?